Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KORU Medical Systems, Inc. Director's Dealing 2021

Feb 4, 2021

33778_dirs_2021-02-04_5fcd7fe4-8b3f-4a40-a154-5fb61909c424.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: REPRO MED SYSTEMS INC (KRMD)
CIK: 0000704440
Period of Report: 2020-12-31

Reporting Person: Goldberger Daniel S (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-13 Common Stock, $0.01 par value G 94422 $0.00 Disposed 6390 Direct

Footnotes

F1: On November 13, 2020, the reporting person gifted 94,422 shares of common stock, $0.01 par value, to the D.S.G. Charitable Remainder Trust (the "Trust"). The Trust is an irrevocable trust, of which Massachusetts Institute of Technology is the sole trustee. The reporting person disclaims beneficial ownership of the shares gifted to the Trust.